Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Among men, the between-group difference in risk for obesity-related cancers (HR = 0.95
Tirzepatide is FDA-approved for weight loss under the brand name Zepbound, while Retatrutide is still in clinical trials and not yet available on the market
Recommencing GLP-1 RAs when the shortage has passed
A Diabetes-Specific Approach At the height of semaglutide shortages in 2023, experts from the American Diabetes Association published recommendations around how to prescribe lower doses for patients with diabetes
Administered as a once-weekly subcutaneous injection, Ozempic has shown benefits in glycaemic control and, in the SUSTAIN-6 trial, demonstrated cardiovascular outcomes, though its licensed indication remains for glycaemic control
US$ 25.40
US$ 27.54
US$ 24.73
US$ 26.60
US$ 25.01
US$ 20.72
US$ 26.16
US$ 29.56
US$ 21.48
US$ 24.95
US$ 27.94
US$ 26.67
US$ 29.83
US$ 23.29
